title: Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis.
abstract: Angiogenesis is involved in various physiologic and pathological conditions, including tumor growth, and is tightly regulated by the orchestration of proangiogenic and antiangiogenic factors. Inhibition of vascular endothelial growth factor (VEGF), the best-established antiangiogenic treatment in cancer, has shown some effectiveness; however, the identification of novel regulators, whose function is independent of VEGF, is required to achieve better outcomes. Here, we show that transcription factor 8 (TCF8) is up-regulated in endothelial cells during angiogenesis, acting as a negative regulator. Furthermore, TCF8 is specifically expressed in the endothelium of tumor vessels. Tcf8-heterozygous knockout mice are more permissive than wild-type mice to the formation of tumor blood vessels in s.c. implanted melanoma, which seems to contribute to the more aggressive growth and the lung metastases of the tumor in mutant mice. Suppression of TCF8 facilitates angiogenesis in both in vitro and ex vivo models, and displays comprehensive cellular phenotypes, including enhanced cell invasion, impaired cell adhesion, and increased cell monolayer permeability due to, at least partly, MMP1 overexpression, attenuation of focal adhesion formation, and insufficient VE-cadherin recruitment, respectively. Taken together, our findings define a novel, integral role for TCF8 in the regulation of pathologic angiogenesis, and propose TCF8 as a target for therapeutic intervention in cancer.
authors.affiliation: Laboratory of Pathophysiology and Signal Transduction, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Takayuki
authors.initials: T
authors.lastname: Inuzuka
authors.forename: Masumi
authors.initials: M
authors.lastname: Tsuda
authors.forename: Shinya
authors.initials: S
authors.lastname: Tanaka
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kawaguchi
authors.forename: Yujiro
authors.initials: Y
authors.lastname: Higashi
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Ohba
mesh_terms: D000818:Animals; D002843:Chromatin / Q000235:genetics; D004151:Dipeptides / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000502:physiology / Q000503:physiopathology; D018398:Homeodomain Proteins / Q000235:genetics / Q000502:physiology*; D006706:Homeostasis; D006801:Humans; D008546:Melanoma, Experimental / Q000098:blood supply* / Q000473:pathology; D045726:Metalloproteases / Q000037:antagonists & inhibitors; D051379:Mice; D018345:Mice, Knockout; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000503:physiopathology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D014471:Umbilical Veins; D014945:Wound Healing / Q000235:genetics / Q000502:physiology; D000071799:Zinc Finger E-box-Binding Homeobox 1
chemical_list: D002843:Chromatin; D004151:Dipeptides; D018398:Homeodomain Proteins; D045726:Metalloproteases; D014157:Transcription Factors; C078131:N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide; C519422:ZEB1 protein, mouse; D000071799:Zinc Finger E-box-Binding Homeobox 1